Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
Go back to Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program| (NASDAQ: TRVI) | Delayed: 14.64 +1.18 (8.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.46 | 52 Week High | $ | |||
| Open | $13.55 | 52 Week Low | $ | |||
| Day High | $14.72 | P/E | N/A | |||
| Day Low | $13.52 | EPS | $ | |||
| Volume | 371,390 | |||||
